SHILPAMED.NSSHILPAMED.NSNSE
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR+5.3%
5Y CAGR-40.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+5.3%/yr
Annual compound
5Y CAGR
-40.1%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202523.46%
2024428.15%
2023-82.23%
202220.11%
20211.33%
2020303.75%
20193.95%
2018-8.26%
2017-37.13%
201671.38%